167 related articles for article (PubMed ID: 8719521)
1. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
Behboudi S; Morein B; Rönnberg B
Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
[TBL] [Abstract][Full Text] [Related]
2. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
[TBL] [Abstract][Full Text] [Related]
3. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
Rönnberg B; Fekadu M; Morein B
Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.
Behboudi S; Morein B; Villacres-Eriksson M
Cytokine; 1997 Sep; 9(9):682-7. PubMed ID: 9325017
[TBL] [Abstract][Full Text] [Related]
6. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
7. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids.
Behboudi S; Morein B; Villacres-Eriksson M
Clin Exp Immunol; 1996 Jul; 105(1):26-30. PubMed ID: 8697631
[TBL] [Abstract][Full Text] [Related]
8. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms.
Dotsika E; Karagouni E; Sundquist B; Morein B; Morgan A; Villacres-Eriksson M
Scand J Immunol; 1997 Mar; 45(3):261-8. PubMed ID: 9122615
[TBL] [Abstract][Full Text] [Related]
9. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
[TBL] [Abstract][Full Text] [Related]
10. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A.
Kamstrup S; San Martin R; Doberti A; Grande H; Dalsgaard K
Vaccine; 2000 Apr; 18(21):2244-9. PubMed ID: 10717344
[TBL] [Abstract][Full Text] [Related]
12. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
Copland MJ; Rades T; Davies NM
Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
[TBL] [Abstract][Full Text] [Related]
13. Saponin Interactions with Model Membrane Systems - Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs.
de Groot C; Müller-Goymann CC
Planta Med; 2016 Dec; 82(18):1496-1512. PubMed ID: 27760443
[TBL] [Abstract][Full Text] [Related]
14. On the preparation, microscopic investigation and application of ISCOMs.
Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
Micron; 2006; 37(8):724-34. PubMed ID: 16750912
[TBL] [Abstract][Full Text] [Related]
15. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
[TBL] [Abstract][Full Text] [Related]
16. Iscom, a delivery system for parenteral and mucosal vaccination.
Morein B; Villacrés-Eriksson M; Lövgren-Bengtsson K
Dev Biol Stand; 1998; 92():33-9. PubMed ID: 9554257
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanticity and ISCOM formation by structurally diverse saponins.
Bomford R; Stapleton M; Winsor S; Beesley JE; Jessup EA; Price KR; Fenwick GR
Vaccine; 1992; 10(9):572-7. PubMed ID: 1502835
[TBL] [Abstract][Full Text] [Related]
18. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
[TBL] [Abstract][Full Text] [Related]
19. Saponins from
Fleck JD; Betti AH; da Silva FP; Troian EA; Olivaro C; Ferreira F; Verza SG
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621160
[No Abstract] [Full Text] [Related]
20. Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria.
Nyberg NT; Baumann H; Kenne L
Anal Chem; 2003 Jan; 75(2):268-74. PubMed ID: 12553761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
